ArticleOncotarget2023

Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma.

Barbara Marengo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.